Disability Transplant Expense Provision

A Disability Transplant Expense Provision is a provision in a disability insurance policy that covers the cost of an organ transplant in the event that the insured becomes disabled and requires a transplant as part of their treatment. This provision is often included as an optional rider to a disability insurance policy and can provide valuable coverage for individuals who are at risk of developing conditions that may require an organ transplant.

Key features of a Disability Transplant Expense Provision may include:

  • Coverage for the cost of the transplant procedure, including hospitalization, surgery, and follow-up care.

  • Coverage for travel expenses associated with obtaining the transplant, such as transportation and lodging costs.

  • Coverage for pre- and post-transplant expenses, such as medication and rehabilitation.

  • Limits on the amount of coverage provided for each transplant, as well as limits on the total amount of coverage available under the rider.

  • Exclusions for certain pre-existing conditions or other health factors that may make an individual ineligible for coverage under the provision.

For example, suppose an individual purchases a disability insurance policy with a Transplant Expense Provision rider. If the individual becomes disabled and requires a kidney transplant, the policy would provide coverage for the cost of the transplant procedure, as well as any associated travel and medical expenses. The amount of coverage provided by the rider would be subject to the limits and exclusions outlined in the policy.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.